Form D · Biotechnology
ACT BIOTECH INC
San Francisco, CA · CIK 0001434913
Offering snapshot reported Jun 11, 2010 · SEC filing
- Reported sold
- $1M Offering amount: $4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 3, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2010 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| May 3, 2010 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Oct 14, 2009 | Initial | $500,000 | No comparison | 1 | SEC filing |
| May 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-143366
Source: Form D, filed Jun 11, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nils C. Behnke | Director |
| Wolf Dieter Busse | Director, Executive |
| John Costantino | Director |
| Ali Fattaey | Executive |
| Gary Lazar | Director |
| John Mahoney | Executive |
| Georg Nebgen | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
717 Market Street, Suite 650
San Francisco, CA, 94103
San Francisco, CA, 94103